Efficacy and safety of fosravuconazole L‐lysine ethanolate, a novel oral triazole antifungal agent, for the treatment of onychomycosis: A multicenter, double‐blind, randomized phase III study

The Journal of Dermatology, EarlyView.


https://ift.tt/2LCE4ql